Comparative Effectiveness Funding In Stimulus Bill Raises Some Red Flags
Executive Summary
Industry observers see red flags in how House Democrats have structured the language related to comparative effectiveness in the economic stimulus bill, with questions on how the money will be spent as well as its potential to leave the door open for cost-effectiveness comparisons of medical products
You may also be interested in...
PCORI’s Slow Start On Comparative Research May Protect It From Political Heat
The Patient-Centered Outcomes Research Institute’s slow ramp-up to being in a position to fund comparative research projects may actually help it survive a heated political environment in an election year.
Comparative Effectiveness “Infrastructure” Could Get Discretionary Funding
The $400 million discretionary fund for comparative effectiveness research to be administered by the secretary of Health and Human Services might not be used for research at all
Comparative Effectiveness “Infrastructure” Could Get Discretionary Funding
The $400 million discretionary fund for comparative effectiveness research to be administered by the secretary of Health and Human Services might not be used for research at all